ES2173203T3 - Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion. - Google Patents

Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.

Info

Publication number
ES2173203T3
ES2173203T3 ES95937526T ES95937526T ES2173203T3 ES 2173203 T3 ES2173203 T3 ES 2173203T3 ES 95937526 T ES95937526 T ES 95937526T ES 95937526 T ES95937526 T ES 95937526T ES 2173203 T3 ES2173203 T3 ES 2173203T3
Authority
ES
Spain
Prior art keywords
ets
composition
formulation
infectant
allows
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95937526T
Other languages
English (en)
Inventor
William Joseph Bologna
Howard Leslie Levine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia Laboratories Bermuda Ltd
Original Assignee
Columbia Laboratories Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Laboratories Bermuda Ltd filed Critical Columbia Laboratories Bermuda Ltd
Application granted granted Critical
Publication of ES2173203T3 publication Critical patent/ES2173203T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA COMPOSICION Y USO DE UNA COMPOSICION QUE INCLUYE UNA FORMULACION POLIMERICA DE ACIDO POLICARBOXILICO DE ENLACE CRUZADO BIOADHESIVO QUE PERMITE EL USO DE CANTIDADES RELATIVAMENTE BAJAS DE AGENTES ANTI-STD COMO N-9, PARA SER USADOS EN LA PREVENCION DE LA INFECCION POR ETS SIN PROVOCAR LA IRRITACION DEL TEJIDO GENITAL QUE A MENUDO ACOMPAÑA A LAS DOSIS MAYORES DE ANTI-ETS. EL POLIMERO BIOADHESIVO MANTIENE UN CONTACTO MAYOR ENTRE EL AGENTE ANTI ETS Y EL INFECTANTE DURANTE UN PERIODO MUCHO MAYOR DE TIEMPO, PERMITIENDO CON UNA CONCENTRACION INFERIOR ACTUAR POR MAS TIEMPO SOBRE EL INFECTANTE, CUANDO SE COMPARA CON LAS APLICACIONES COMERCIALES NORMALMENTE DISPONIBLES QUE CONTIENEN N-9. TAL SUMINISTRO DA UNA SEGURIDAD Y PERMITE UNA DISMINUCION NO IRRITANTE EN EL RIESGO DE SUFRIR UNA INFECCION ETS, INCLUYENDO HIV.
ES95937526T 1994-10-07 1995-10-06 Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion. Expired - Lifetime ES2173203T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
ES2173203T3 true ES2173203T3 (es) 2002-10-16

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95937526T Expired - Lifetime ES2173203T3 (es) 1994-10-07 1995-10-06 Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.

Country Status (24)

Country Link
US (2) US5667492A (es)
EP (1) EP0784466B1 (es)
JP (1) JPH10507178A (es)
KR (1) KR970705976A (es)
AT (1) ATE213623T1 (es)
AU (1) AU704836B2 (es)
BR (1) BR9509280A (es)
CA (1) CA2201872A1 (es)
CO (1) CO4480018A1 (es)
DE (1) DE69525634T2 (es)
DK (1) DK0784466T3 (es)
ES (1) ES2173203T3 (es)
FI (1) FI971440A7 (es)
HU (1) HUT77527A (es)
IL (1) IL115495A0 (es)
MA (1) MA23687A1 (es)
MX (1) MX9504245A (es)
NO (1) NO971491L (es)
NZ (1) NZ295947A (es)
PE (1) PE46996A1 (es)
PT (1) PT784466E (es)
RU (1) RU2157184C2 (es)
WO (1) WO1996010989A1 (es)
ZA (1) ZA958434B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007194A1 (es) * 2003-07-16 2005-01-27 Italfarmaco, S.A. Formulaciones mucoadhesivas semisólidas

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
EP1356806A1 (en) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
KR20010083057A (ko) 1998-06-19 2001-08-31 추후제출 항-감염 및 피임성을 갖는 의료 장치
WO1999066900A2 (de) * 1998-06-23 1999-12-29 Notax Holding Gesellschaft Mbh Verwendung von nonoxynol-9 als gleitmittel sowie verfahren zu seiner herstellung
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
RU2310474C2 (ru) 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
PL202918B1 (pl) * 2000-03-07 2009-08-31 Rush Presbyterian St Luke Przeciwbakteryjna i antykoncepcyjna kompozycja oraz jej zastosowanie
PT1997478E (pt) * 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
HRP20040421B1 (hr) * 2001-10-16 2013-05-31 Avanir Pharmaceuticals INHIBICIJA VIRUSA n-DOKOZANOLOM
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
RU2200570C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий сперматоцидным эффектом и активностью в отношении инфекций, передаваемых половым путем
RU2200572C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий противоинфекционным действием в отношении инфекций, передаваемых половым путем
RU2200571C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, активный в отношении вирусных и других инфекций, передаваемых половым путем
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN110693812A (zh) 2012-06-13 2020-01-17 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
AU2014368971B2 (en) 2013-12-19 2020-02-06 Evofem, Inc. Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
CN105250280B (zh) * 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
CN110225750A (zh) 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (es) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0163696B1 (en) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Use of a bioadhesive
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
MC2204A1 (fr) * 1989-10-31 1992-11-26 Columbia Lab Inc Composition et methode d'humidification de tissus
ES2059300T3 (es) * 1989-10-31 1994-12-01 Columbia Lab Inc Metodo de humidificacion de tejidos y composicion.
DE69014081T2 (de) * 1989-10-31 1995-03-30 Columbia Laboratories, Inc., Miami, Fla. Mittel zur Feuchthaltung vaginalen Gewebes.
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007194A1 (es) * 2003-07-16 2005-01-27 Italfarmaco, S.A. Formulaciones mucoadhesivas semisólidas
ES2237298A1 (es) * 2003-07-16 2005-07-16 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
US8663688B2 (en) 2003-07-16 2014-03-04 Itf Research Pharma, S.L.U. Semi-solid mucoadhesive formulations

Also Published As

Publication number Publication date
JPH10507178A (ja) 1998-07-14
NO971491L (no) 1997-06-09
MA23687A1 (fr) 1996-07-01
EP0784466B1 (en) 2002-02-27
DK0784466T3 (da) 2002-04-22
PE46996A1 (es) 1996-11-23
NO971491D0 (no) 1997-04-02
IL115495A0 (en) 1996-01-19
FI971440L (fi) 1997-04-07
BR9509280A (pt) 1997-11-18
NZ295947A (en) 1999-02-25
HUT77527A (hu) 1998-05-28
EP0784466A1 (en) 1997-07-23
AU704836B2 (en) 1999-05-06
CA2201872A1 (en) 1996-04-18
FI971440A0 (fi) 1997-04-07
RU2157184C2 (ru) 2000-10-10
ZA958434B (en) 1996-05-08
ATE213623T1 (de) 2002-03-15
DE69525634D1 (de) 2002-04-04
KR970705976A (ko) 1997-11-03
US5667492A (en) 1997-09-16
MX9504245A (es) 1997-01-31
FI971440A7 (fi) 1997-04-07
AU3961295A (en) 1996-05-02
CO4480018A1 (es) 1997-07-09
PT784466E (pt) 2002-06-28
DE69525634T2 (de) 2002-08-29
US20010006667A1 (en) 2001-07-05
WO1996010989A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
ES2173203T3 (es) Composicion que comprende una formulacion que actua contra las enfermedades sexualmente transmisibles y su utilizacion.
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
JP2988658B2 (ja) 非水性皮膚軟化剤入りヨードフォア製剤
US9687387B2 (en) System and methods for treating ear disorders
ES2105332T3 (es) Polimeros quelantes.
ES2115733T3 (es) Composicion antialergica para uso oftalmico o nasal.
ATE455526T1 (de) Nicht-hormonales vaginales verhütungsmittel
BR9810084A (pt) Panos antimicrobianos
PE3296A1 (es) Composicion oral conteniendo un mucoadhesivo
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
ATE227976T1 (de) Lösungen als träger für augenarzneien
ES2071322T3 (es) Reduccion o prevencion de la irritacion de la piel por farmacos.
ES2093400T3 (es) Composiciones dentifricas.
AR035509A1 (es) Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
WO1990008559A1 (en) Biodegradable disinfectant
US8518434B2 (en) Antiseptic spermicidal composition and means for its application
GT200000105A (es) Sal difosfato de un derivado de 4" - sustituido - 9 - desoxo - 9a - aza - 9a - homoeritromicina y sucomposicion farmaceutica.
JP2003095952A (ja) 眼科組成物及び該組成物の抗菌力増強方法
ES2080847T3 (es) Utilizacion de naproxen como agente midriatico.
ES2063700B1 (es) Agente activo sobre el sistema nervioso central, proceso para su preparacion y composiciones farmaceuticas que lo contengan.
AR024654A1 (es) Composiciones de antibioticos de quinolona y uso de dichos antibioticos para la preparacion de dichas composiciones de aplicacion ocular en mamiferos.
Makulowich HIV and STD Prevention Update: Alternatives to the Male Condom
Park Intracanal medication
ES2051643B1 (es) Formulaciones orales de ubidecarenona en forma de soluciones acuosas.
CO5580798A2 (es) Composicion de peroxido de liberacion prolongada para infecciones vaginales

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784466

Country of ref document: ES